Well Lead Medical Co., Ltd.

Equities

603309

CNE1000021C2

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
12.23 CNY +2.77% Intraday chart for Well Lead Medical Co., Ltd. +25.18% -14.05%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Mainland China and Hong Kong stocks fall on Middle East tensions RE
Well Lead Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Well Lead Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Well Lead Medical Wins EU Certification For Two Catheters MT
Well Lead Medical Gets Three EU Regulation Certifications for Medical Devices MT
Well Lead Medical Gets Certificate for Silicone Ureteral Stent Kit MT
Well Lead Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Well Lead Medical Co., Ltd.(XSSC:603309) added to S&P Global BMI Index CI
Well Lead Medical's Unit Obtains Certificates for Two Devices MT
Well Lead Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Well Lead Medical Gets FDA Nod to Market Catheter in the US MT
Well Lead Medical Gets EU Certificate for Two Devices MT
Well Lead Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Well Lead Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Well Lead Medical Gets Registration Certificate for Breathing Circuit Pack MT
Well Lead Medical’s Ureteral Catheter Wins FDA Nod MT
Well Lead Medical Forms Shock Wave Therapy Equipment JV MT
Well Lead Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Well Lead Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Well Lead Medical Wins FDA Approval to Register Nasal Jet Tube in US MT
Well Lead Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Well Lead Medical Co., Ltd. announced that it has received CNY 399.442299 million in funding from a group of investors CI
Well Lead Medical Co., Ltd. agreed to acquire 19.8% stake in Suzhou Medsure Medical Technology Co., Ltd. from Shenzhen Futian Co-Win Health Industry Investment Fund Partnership Ent. (L.P.) managed by Shenzhen Co-Win Jinxiu Asset Management Limited for CNY12.7 million. CI
Well Lead Medical Co., Ltd. agreed to acquire 31.7% stake in Suzhou Medsure Medical Technology Co., Ltd. from Wang Guangming for CNY 17.7 million. CI
Well Lead Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Chart Well Lead Medical Co., Ltd.
More charts
WELL LEAD MEDICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and sales of catheters used for anesthesia, urinary, breathing, blood dialysis and other fields. The Company's major products include endotracheal intubations, urethral catheters, laryngeal masks, hemodialysis catheters and others. The Company's products are mainly applied in medical fields such as surgery, treatment, emergency treatment and nursing. The Company distributes its products in domestic market and overseas markets.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
12.23
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603309 Stock
  4. News Well Lead Medical Co., Ltd.
  5. Well Lead Medical Forms Shock Wave Therapy Equipment JV